Parinaz Emami, Ph.D., is a Strategy Consultant I at IQVIA since August 2022, with a focus on corporate and portfolio strategy. Emami has a strong background in competitive market analysis, financial modeling, and strategic planning, with expertise in both US and EU market dynamics. Prior to this role, Emami served as a Strategy Consultant at Merck and as a Senior Scientist leading operations in continuous processing labs. Emami's research experience includes significant roles at Pfizer and Penn State, where a framework for optimizing impurity removal from conjugated vaccines was developed. Educational achievements include a Ph.D. in Chemical Engineering from Penn State University, an MS from the University of Missouri-Columbia, and a BS from Sharif University of Technology.